meta Joint Venture Boosts Investment in Methane Vaccine to Lower Farm Emissions Globally :: The Bullvine - The Dairy Information You Want To Know When You Need It

Joint Venture Boosts Investment in Methane Vaccine to Lower Farm Emissions Globally

Discover how AgriZeroNZ’s $9.9 million investment in ArkeaBio could revolutionize farm emissions with a methane vaccine. Could this be the key to global climate goals?

A joint venture that is committed to reducing on-farm emissions is solidifying their efforts to create a revolutionary methane vaccine. This partnership has piqued the agricultural industry’s interest not just for its novel approach, but also for its potential to redefine how the world perceives farming emissions. The venture in question, AgriZeroNZ, is an enterprise owned by the government and reputable participants in the primary industries. 

AgriZeroNZ is making substantial investment to the tune of $9.9 million in US company ArkeaBio. ArkeaBio’s main objective is to create a methane vaccine for ruminant animals, a pioneering move that could greatly lessen the carbon footprint of farms worldwide. 

“A methane vaccine for ruminant animals is internationally recognised as the ‘holy grail’ to deliver methane reduction at low cost and mass scale. It could be one of the best long-term options to really shift the dial on agricultural emissions in New Zealand without compromising farm profitability, as well as a powerful tool globally,” stated Wayne McNee, the CEO of AgriZeroNZ.

This strategic investment is a follow-up step after a previous investment into research in New Zealand for vaccine creation. AgriZeroNZ’s funding aids the US research to heighten the chance of delivering a first-of-its-kind resolution to the problem of harmful methane emissions

ArkeaBio, led by the Kiwi expatriate Colin South, recently raised an impressive US$26.5m in Series A venture financing. This capital will fuel the development and subsequent trial of the methane vaccine. 

 Expressing his satisfaction, Colin South mentioned, “A vaccine is the lowest cost path to global scale enteric methane reduction and is applicable to cattle worldwide. This singular solution, distributed globally with large-scale adoption, can change the trajectory of global warming and demonstrate a path to meeting major climate mitigation goals.”

Summary: AgriZeroNZ, a government-owned enterprise, is investing $9.9 million in US company ArkeaBio to create a methane vaccine for ruminant animals. This innovative approach could significantly reduce the carbon footprint of farms worldwide. AgriZeroNZ’s CEO, Wayne McNee, believes a methane vaccine for ruminant animals is the “holy grail” for delivering low-cost and mass-scale methane reduction. This strategic investment follows a previous investment in New Zealand’s vaccine creation research. AgriZeroNZ’s funding supports US research to deliver a first-of-its-kind solution to harmful methane emissions. ArkeaBio, led by Kiwi expatriate Colin South, raised $26.5m in Series A venture financing to fuel the development and trial of the methane vaccine. South believes that a vaccine is the lowest-cost path to global scale enteric methane reduction and is applicable to cattle worldwide. This solution, distributed globally with large-scale adoption, could change the trajectory of global warming and demonstrate a path to meeting major climate mitigation goals.

Send this to a friend